RAN and amyotrophic lateral sclerosis: On the other hand, RAN translation products have demonstrated a key role in C9orf72 FTD/ALS pathogenesis, however most recent literature supports a model where a combination of C9orf72 haploinsufficiency and gain of function toxic mechanisms might drive disease pathogenesis via a synergistic effect [47,48,49].